THYROCARE — Thyrocare Technologies Share Price
0.000.00%
Last trade - 00:00- IN₹41.65bn
- IN₹40.59bn
- IN₹5.72bn
- 98
- 17
- 97
- 86
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 37.16 | ||
| PEG Ratio (f) | 1.55 | ||
| EPS Growth (f) | 31.46% | ||
| Dividend Yield (f) | 1.63% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 7.91 | ||
| Price to Tang. Book | 9.87 | ||
| Price to Free Cashflow | 39.28 | ||
| Price to Sales | 7.01 | ||
| EV to EBITDA | 27.7 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 17.71% | ||
| Return on Equity | 14.63% | ||
| Operating Margin | 16.5% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | IN₹m | 4,332 | 4,946.2 | 5,888.6 | 5,266.7 | 5,718.8 | 6,501 | 7,560 | 7.26% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +10.74 | +17.5 | +60.27 | -62.8 | +9.96 | +37.33 | +27.57 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Thyrocare Technologies Limited is a healthcare services provider in the diagnostic area. It has diagnostic chains that conduct a range of medical diagnostic tests and profiles of tests that are focused on early detection and management of health disorders and diseases. Its segments include Diagnostic Testing Services, Imaging Services and Others. The Diagnostic Testing Services segment includes diagnostic and testing services, selling of consumables used for collection and promotion of pathology. Imaging Services includes diagnostic and imaging services, selling of radio-pharmaceuticals, selling of consumables for reporting. The Others segment includes the sale of testing equipment and consumables, and selling of glucometer and glucostrips under the brand, Sugarscan. It has a centralized fully automated diagnostic testing laboratory, regional processing laboratories, a medical cyclotron facility and PET-CT facilities across India. It also focuses on the pathology diagnostic business.
Directors
- Amruta Velumani CHM (59)
- Sachin Salvi CFO (41)
- Ramjee Dorai GCN (59)
- M. Chandrasekhar GMG (32)
- M. Santhosh GMG (34)
- A. Sundararaju EDR (63)
- S. Krishnakumar OTH (45)
- Rajkumar Kushawaha OTH (36)
- Caesar Sengupta OTH (41)
- Indumati Gopinathan NED
- Sumathi Velumani NED (55)
- Neetin Desai NID (46)
- Gopal Hegde NID (56)
- Vishwas Kulkarni NID (54)
- N. Palanisamy NID (67)
- Last Annual
- March 31st, 2024
- Last Interim
- June 30th, 2024
- Incorporated
- January 28th, 2000
- Public Since
- May 9th, 2016
- No. of Shareholders
- 65,744
- No. of Employees
- 1,693
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- National Stock Exchange of India
- Shares in Issue
- 52,952,676
- Address
- D-37/1, Midc, Turbhe, Opp., Sandoz, NAVI MUMBAI, 400703
- Web
- https://www.thyrocare.com/
- Phone
- +91 2241252525
- Contact
- Ramjee Dorai
- Auditors
- MSKA & Associates
Upcoming Events for THYROCARE
Q3 2025 Thyrocare Technologies Ltd Earnings Release
Similar to THYROCARE
Aatmaj Healthcare
National Stock Exchange of India
Apollo Hospitals Enterprise
National Stock Exchange of India
Artemis Medicare Services
National Stock Exchange of India
Aster DM Healthcare
National Stock Exchange of India
Dr. Lal PathLabs
National Stock Exchange of India
FAQ
What is the Thyrocare Technologies share price?
As of Today at 23:41 UTC, shares in Thyrocare Technologies are trading at IN₹786.60. This share price information is delayed by 15 minutes.
How has the Thyrocare Technologies share price performed this year?
Shares in Thyrocare Technologies last closed at IN₹786.60 and the price had moved by +37.17% over the past 365 days. In terms of relative price strength the Thyrocare Technologies share price has outperformed the S&P BSE 100 Index by +4.59% over the past year.
What are the analyst and broker recommendations for Thyrocare Technologies?
The overall consensus recommendation for Thyrocare Technologies is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the Thyrocare Technologies dividend yield?
The Thyrocare Technologies dividend yield is 2.29% based on the trailing twelve month period.
Does Thyrocare Technologies pay a dividend?
Last year, Thyrocare Technologies paid a total dividend of IN₹18.00, and it currently has a trailing dividend yield of 2.29%. We do not have any data on when Thyrocare Technologies is to next pay dividends.
When does Thyrocare Technologies next pay dividends?
We do not have data on when Thyrocare Technologies is to next pay dividends. The historic dividend yield on Thyrocare Technologies shares is currently 2.29%.
How do I buy Thyrocare Technologies shares?
To buy shares in Thyrocare Technologies you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Thyrocare Technologies?
As of the previous close price of IN₹786.60, shares in Thyrocare Technologies had a market capitalisation of IN₹41.65bn.
Where are Thyrocare Technologies shares listed?
Here are the trading details for Thyrocare Technologies:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: THYROCARE
What kind of share is Thyrocare Technologies?
Based on an overall assessment of its quality, value and momentum Thyrocare Technologies is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Thyrocare Technologies share price forecast for 2024?
The analyst consensus target price for shares in Thyrocare Technologies is IN₹825.00. That is 4.88% above the last closing price of IN₹786.60.
Analysts covering Thyrocare Technologies currently have a consensus Earnings Per Share (EPS) forecast of IN₹18.50 for the next financial year.
Find out moreWhat is the trend in the Thyrocare Technologies share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Thyrocare Technologies. Over the past six months, its share price has outperformed the S&P BSE 100 Index by +15.04%.
As of the last closing price of IN₹786.60, shares in Thyrocare Technologies were trading +14.52% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Thyrocare Technologies PE Ratio?
The Thyrocare Technologies PE ratio based on its reported earnings over the past 12 months is 37.16. The shares last closed at IN₹786.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Thyrocare Technologies?
Thyrocare Technologies' management team is headed by:
- Amruta Velumani - CHM
- Sachin Salvi - CFO
- Ramjee Dorai - GCN
- M. Chandrasekhar - GMG
- M. Santhosh - GMG
- A. Sundararaju - EDR
- S. Krishnakumar - OTH
- Rajkumar Kushawaha - OTH
- Caesar Sengupta - OTH
- Indumati Gopinathan - NED
- Sumathi Velumani - NED
- Neetin Desai - NID
- Gopal Hegde - NID
- Vishwas Kulkarni - NID
- N. Palanisamy - NID